| Lilia Teresa Nunez Negron, MD | |
|
489 King Ave Apt J3, Collingswood, NJ 08108-1459 | |
| (609) 238-6433 | |
| Not Available |
| Full Name | Lilia Teresa Nunez Negron |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 33 Years |
| Location | 489 King Ave Apt J3, Collingswood, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922647270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 0101268326 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gmgp Health Group, Llc | 9436561800 | 8 |
News Archive
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.
Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.
Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with praVAstatin In Lowering LDL-C in the U.S.) which evaluated the efficacy of LIVALO (pitavastatin) 4 mg compared with pravastatin 40 mg in reducing low-density lipoprotein cholesterol (LDL-C), the primary endpoint, as well as effects on other lipid parameters and lipoprotein particles in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010.
› Verified 9 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780868547 PECOS PAC ID: 9739260019 Enrollment ID: O20100107000671 |
News Archive
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.
Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.
Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with praVAstatin In Lowering LDL-C in the U.S.) which evaluated the efficacy of LIVALO (pitavastatin) 4 mg compared with pravastatin 40 mg in reducing low-density lipoprotein cholesterol (LDL-C), the primary endpoint, as well as effects on other lipid parameters and lipoprotein particles in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010.
› Verified 9 days ago
| Entity Name | National Health Rehabilitation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780080218 PECOS PAC ID: 4284952615 Enrollment ID: O20200212001804 |
News Archive
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.
Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.
Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with praVAstatin In Lowering LDL-C in the U.S.) which evaluated the efficacy of LIVALO (pitavastatin) 4 mg compared with pravastatin 40 mg in reducing low-density lipoprotein cholesterol (LDL-C), the primary endpoint, as well as effects on other lipid parameters and lipoprotein particles in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010.
› Verified 9 days ago
| Entity Name | Gmgp Health Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144838608 PECOS PAC ID: 9436561800 Enrollment ID: O20201209002470 |
News Archive
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.
Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.
Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with praVAstatin In Lowering LDL-C in the U.S.) which evaluated the efficacy of LIVALO (pitavastatin) 4 mg compared with pravastatin 40 mg in reducing low-density lipoprotein cholesterol (LDL-C), the primary endpoint, as well as effects on other lipid parameters and lipoprotein particles in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lilia Teresa Nunez Negron, MD 489 King Ave Apt J3, Collingswood, NJ 08108-1459 Ph: (609) 238-6433 | Lilia Teresa Nunez Negron, MD 489 King Ave Apt J3, Collingswood, NJ 08108-1459 Ph: (609) 238-6433 |
News Archive
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.
Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.
Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with praVAstatin In Lowering LDL-C in the U.S.) which evaluated the efficacy of LIVALO (pitavastatin) 4 mg compared with pravastatin 40 mg in reducing low-density lipoprotein cholesterol (LDL-C), the primary endpoint, as well as effects on other lipid parameters and lipoprotein particles in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010.
› Verified 9 days ago